Why the study?
Does the elevation of serum enzymes (SGOT, LDH) correlate with myocardial infarct size in experimental models?
Does the elevation of serum enzymes (SGOT, LDH) correlate with myocardial infarct size in experimental models?
This preclinical study aimed to assess the correlation between serum enzyme elevations and myocardial infarct size, though results are not reported in the truncated abstract.
Does not inform clinical practice; leaves open whether serum enzymes correlate with infarct size in experimental models.
THERE IS no known accurate technique of clinical quantitation of myocardial infarct size.1During the past decade practical methods of measuring the serum values of certain enzymes, present in abnormally elevated levels in the presence of myocardial necrosis, have been applied widely as diagnostic tests for the presence of myocardial infarction. The reliability of the correlation of infarct size with the magnitude of serum enzyme elevation has not been precisely established. A method based on myocardial distribution of intravenously administered radioactive rubidium (86Rb) has been used recently to quantitate the size of experimentally produced myocardial infarcts. In the present study the elevation of the serum glutamic oxaloacetic transaminase (SGOT), lactic dehydrogenase (LDH), and heat stable lactic dehydrogenase (LDH) following coronary artery ligation was assessed in relation to myocardial infarct size as determined by macroscopic examination (dissection) at autopsy and by the radioactive rubidium distribution technique Methods Myocardial infarcts
No takes yet. Share an insight, caveat, or question.
Duncan A. Killen (1966) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: